Ventas Inc. diskutieren
Ventas, Inc. (NYSE: VTR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for VTR provided by MarketBeat
Ventas, Inc. (NYSE: VTR) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Ratings data for VTR provided by MarketBeat
Ventas, Inc. (NYSE: VTR) had its price target raised by analysts at Wedbush from $69.00 to $78.00. They now have an "outperform" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas, Inc. (NYSE: VTR) had its price target raised by analysts at Royal Bank of Canada from $70.00 to $74.00. They now have an "outperform" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas, Inc. (NYSE: VTR) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
Ratings data for VTR provided by MarketBeat
Ventas, Inc. (NYSE: VTR) had its price target raised by analysts at Wells Fargo & Company from $72.00 to $77.00. They now have an "overweight" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas, Inc. (NYSE: VTR) had its price target raised by analysts at Mizuho from $68.00 to $75.00. They now have an "outperform" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas, Inc. (NYSE: VTR) had its price target raised by analysts at Royal Bank of Canada from $74.00 to $75.00. They now have an "outperform" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas, Inc. (NYSE: VTR) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $72.00 price target on the stock, up previously from $70.00.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $78.00 price target on the stock, up previously from $74.00.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its "buy" rating reaffirmed by analysts at Argus. They now have a $75.00 price target on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its price target raised by analysts at JPMorgan Chase & Co. from $72.00 to $76.00. They now have an "overweight" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its price target raised by analysts at Evercore ISI from $77.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $77.00 price target on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its price target raised by analysts at Cantor Fitzgerald from $77.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its price target raised by analysts at Citigroup Inc. from $80.00 to $88.00. They now have a "buy" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its price target raised by analysts at Wells Fargo & Company from $80.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for VTR provided by MarketBeat
Ventas (NYSE:VTR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $94.00 price target on the stock.
Ratings data for VTR provided by MarketBeat
Neueste Beiträge
StockNews_com in Acadia Pharmaceuticals diskutieren